Danaher Stock News

The Infectious Disease In-vitro Diagnostic Market research report is an effective tool to gain information about the markets competitive landscape by ensuing success in the global Infectious Disease In-vitro Diagnostic Market. The information and data included in the report are

Related Stocks: USRT , JPST , ESGV , IWS , VSGX , LECO , DHR ,

IMS Capital Management raised its holdings in shares of Danaher Co. (NYSE:DHR) by 14.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 6,487 shares of the conglomerates stock after acquiring an additional 818 shares during the period. Danaher makes up 1.1% of IMS Capital Managements holdings, []

Network Point-of-Care Glucose Testing Market: Overview The network point-of-care glucose testing market is rapidly growing on the back of different factors. The integration of testing methods with technologically advanced techniques for data transfer serves as one of the prominent factors for

Curbstone Financial Management Corp decreased its stake in shares of Danaher Co. (NYSE:DHR) by 3.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 4,564 shares of the conglomerates stock after selling 168 shares during the quarter. Curbstone Financial Management Corps holdings in Danaher were []

Data Bridge Market Research analyses that the gene therapy products market will exhibit a CAGR of around 22.15% for the forecast period of 2021-2028. Increasing prevalence of cancer and other life threatening diseases globally, rising expenditure for research and development

According to Stratagem Market Insights'' latest report, the Global Histology and Cytology Market is projected to develop at a rapid pace from 2021 to 2028. During the forecast period, the report proposes to estimate market share in terms of volume.

Chesley Taft & Associates LLC lowered its holdings in shares of Danaher Co. (NYSE:DHR) by 1.1% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 100,840 shares of the conglomerates stock after selling 1,141 shares during the period. Danaher comprises 1.8% of Chesley Taft & Associates LLCs holdings, []

Chesley Taft & Associates LLC lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 1.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 100,840 shares of the conglomerates stock after selling 1,141 shares during the period. Danaher comprises 1.8% []

Private Asset Management Inc. purchased a new position in shares of Danaher Co. (NYSE:DHR) during the third quarter, HoldingsChannel.com reports. The fund purchased 819 shares of the conglomerates stock, valued at approximately $249,000. Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Stonehage Fleming Financial Services []

GE: Lessons From Danaher As Larry Culp Makes A Huge Move

Danaher's recent quarter earnings beat expected results by $0.24 on the bottom line, and top-line beat by 23%, with an excellent gain over last year's results. Danaher's 70-month total return is fanta

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Water has become a multi-billion dollar industry, so these three water stocks should make outstanding additions to any long-term portfolio. The post 3 Worthy Water Stocks to Tap As Drought Becomes a N

Supply-chain, logistics and labor woes are limiting growth in the Zacks Diversified Operations industry. Despite this, DHR, CSL, RAVN and GFF are showing strength and must be on investors' watch list.